Sx
Peripheral Neuropathy
search
Peripheral Neuropathy
, Neuropathy
See Also
Peripheral Nerve Injury
Symmetric Peripheral Neuropathy
(
Polyneuropathy
)
Asymmetric Peripheral Neuropathy
Peripheral Neuropathy Tremor
Medication Causes of Neuropathy
Epidemiology
Prevalence
: 1-7% in general U.S. population (increased over age 50 years)
Pathophysiology
Injury affects one of four components
See
Neuron
Neuron
al or
Axonal Neuropathy
Affects cell body or axon of nerve
See
Symmetric Peripheral Neuropathy
(
Polyneuropathy
)
See
Asymmetric Peripheral Neuropathy
(
Mononeuropathy
)
See
Peripheral Nerve Injury
Diabetes Mellitus
Collagen
vascular disease
Vasculitis
Thyroid
disease
Vitamin Deficiency
(e.g.
Vitamin B12 Deficiency
)
Hereditary Neuropathy
Demyelinating Neuropathy (Myelinopathy)
Affects myelin swan cell sheath around axon
Symmetric Peripheral Neuropathy
(
Polyneuropathy
)
Consider hereditary Neuropathy
Asymmetric Peripheral Neuropathy
(
Mononeuropathy
)
Acute Demyelinating Neuropathy (e.g.
Guillain Barre Syndrome
)
Chronic Inflammatory Demyelinating
Polyneuropathy
Infiltrative Neuropathy: Affects supporting tissue
Appears similar to demyelinating Neuropathy
Sarcoidosis
Myeloma
tosis
Amyloidosis
Ischemic Neuropathy: Affects nerve vascular supply
Diabetes Mellitus
Collagen
vascular disease
Pathophysiology
Nerve
Fiber
Size
Large Nerves
Carry motor and sensory, as well as proprioception and vibration sense
Small Nerves
Carry pain and
Temperature
, as well as
Autonomic System
signals
History
What is the distribution of nerve involvement?
Symmetric:
Polyneuropathy
Usually due to systemic or hereditary condition
Idiopathic in 20% of cases
Asymmetric:
Mononeuropathy
Usually due to nerve compression or inflammation
Mononeuropathy
: Isolated to a single nerve
Mononeuropathy Multiplex
: >1 discrete nerve
Is the deficit sensory, motor or sensorimotor?
Most neuropathies affect both sensory and motor
Pure motor or sensory seen in distal
Mononeuropathy
Is motor more than sensory involvement?
Amyotrophic Lateral Sclerosis
Poliomyelitis
or other chronic infectious cause
Hereditary sensorimotor Neuropathy
Toxin exposure
Is sensory more than motor involvement?
Toxin exposure
Vitamin B12 Deficiency
Hereditary sensory Neuropathy
Systemic condition
Diabetes Mellitus
Uremia
Myeloma
tosis
Dysproteinemia
Are
Cranial Nerve
s Involved (e.g. speech,
Swallowing
, facial,
Tongue
or neck weakness)?
Diabetes Mellitus
Guillain Barre Syndrome
HIV Infection
Lyme Disease
Diphtheria
Sarcoidosis
Tumor invasion of
Meninges
or skull base
Is there
Autonomic Dysfunction
(
Orthostasis
,
Gastroparesis
,
Erectile Dysfunction
, bowel or
Bladder
changes)?
Amyloidosis
Diabetes Mellitus
Lymphoma
Paraneoplastic syndromes
Porphyria
Heavy Metal Toxicity
(e.g. thallium,
Arsenic
,
Mercury Poisoning
)
Are upper extremities predominately affected?
Amyloidosis
(hereditary type II amyloid Neuropathy)
Diabetes Mellitus
Familial Motor Sensory Neuropathy
Guillain Barre Syndrome
Lead Toxicity
Porphyria
Vitamin B12 Deficiency
When was the onset of symptoms?
Acute over hours or days
Consider
Trauma
, ischemia,
Vasculitis
Motor Neuropathy most common
See
Acute Motor Weakness Causes
Acute motor loss is risk for
Respiratory Failure
(e.g.
Guillain Barre Syndrome
)
Requires urgent evaluation
Sensory Neuropathy:
Herpes Zoster
Subacute over days to weeks
Chronic over months to years
Accounts for most cases of Neuropathy
Consider
Medication Causes of Neuropathy
, and metabolic disorders
Other related history
Infectious Disease Risks
HIV Infection
risks
Lyme Disease
risks
Medications
See
Medication Causes of Neuropathy
Also review herbal use
Family History
Neurologic disorders (familial Neuropathy) or skeletal deformity
Exposures
Travel History
Work exposure (e.g.
Heavy Metal
exposure)
Recent
Immunization
s (e.g.
Guillain Barre Syndrome
associations)
Past Medical History
Diabetes Mellitus
Vitamin Deficiency
risks (e.g.
Vitamin B12 Deficiency
)
Connective Tissue Disorder
s,
Rheumatologic Disorder
s or
Vasculitis
(e.g.
Rheumatoid Arthritis
,
Sarcoidosis
)
New bowel and
Bladder
dysfunction (e.g.
Incontinence
, retention)
Associated with central Neuropathy causes (e.g.
Cauda Equina Syndrome
)
Exam
Perform thorough evaluation, including cardiopulmonary exam and skin exam
Complete
Neurologic Exam
(see specific signs below)
See
Neurologic Exam
See
Sensory Exam
See
Motor Exam
See
Deep Tendon Reflex
Signs
Sensory
Specific
Sensory Exam
features
Evaluate for common compression neuropathies (e.g. sciatic nerve, lateral femoral cutaneous,
Median Nerve
)
Identify affected
Dermatome
(s) including over the trunk, comparing to the opposite side
Include vibratory
Sensation
(128 Hz tuning fork) and monofilament (10-g)
Pathognomonic neuropathic findings
Allodynia
(pain from non-painful stimulus - such as light touch)
Hyperalgesia (excessive pain from a painful stimulus)
Demyelinating or infiltrative Neuropathy
Loss of vibration sense
Loss of joint position sense
Loss of tactile discrimination
Axonal Neuropathy
Sensory modes affected equivalently
Neuropathy begins distally and moves proximally
Injured
Nerve Cell
body cannot pump to axon end
Results in stocking-and-glove distribution
Long axons (e.g. legs) lose distal function first
First: Sensory loss begins in feet
Next: Deficit progresses proximally to knees
Next: Hands begin to lose
Sensation
Face is rarely affected (generally short axons)
Signs
Motor
Specific
Motor Exam
features
Stand-Squat-Stand with arms flexed forward in front
Identifies subtle proximal
Muscle Weakness
Unilateral heal raise (arms against wall for support)
Identifies subtle calf weakness
Demyelinating or infiltrative Neuropathy
Early loss of
Deep Tendon Reflex
es
Sensory often affected more than motor function
Axonal Neuropathy
Initial: Damage to anterior horn cell at spinal cord
Weakness
Muscle
wasting
Muscle
Fasciculation
s
Later
Deep Tendon Reflex
loss in chronic Neuropathy
Demyelination may occur secondary to axonal loss
Differentiate from primary demyelination as above
Motor loss follows same pattern as for sensory loss
Distal affected before proximal involvement
Causes
See
Medication Causes of Neuropathy
See
Symmetric Peripheral Neuropathy
(
Polyneuropathy
)
See
Asymmetric Peripheral Neuropathy
(
Mononeuropathy
)
Most common causes
Idiopathic in >25% of cases
Diabetes Mellitus
(25-50% of diabetic patients)
Alcohol
ic Neuropathy
Nerve compression or injury
Toxin exposure
Hereditary Neuropathy causes
Nutritional Deficiency (e.g.
Vitamin B12 Deficiency
)
Painful Neuropathy causes
Alcohol
ic Neuropathy
Amyloidosis
Chemotherapy
See
Medication Causes of Neuropathy
Diabetic Neuropathy
(25-50% of diabetic patients)
Porphyria
Neuropathy with autonomic findings
All painful neuropathies also cause autonomic features
Paraneoplastic syndrome
Heavy Metal Toxicity
Vitamin B12 Deficiency
Differential Diagnosis
Central Neuropathy
Central Neuropathy causes
Myelopathy
Spinal Cord Syndrome
s (e.g. syringmyelia,
Trauma
,
Tabes Dorsalis
)
Upper Motor Neuron
or
Central Nervous System
disorder
Cerebrovascular Accident
Findings that may distinguish central Neuropathy (from Peripheral Neuropathy)
Bilateral sensory deficits with multiple
Dermatome
s affected
Motor deficits are often bilateral (below the level of the lesion)
Upper Motor Neuron Deficit
(spasticity, hyperreflexia,
Clonus
)
Bowel
and
Bladder
dysfunction may be present (e.g.
Cauda Equina Syndrome
)
Loss of
Sensation
rather than the altered
Sensation
of Peripheral Neuropathy (hyperesthesia,
Paresthesia
)
Labs
Initial
Complete Blood Count
(CBC)
Comprehensive metabolic panel (includes
Electrolyte
s,
Liver Function Test
s,
Renal Function
tests)
Erythrocyte Sedimentation Rate
or
C-Reactive Protein
(
C-RP
)
Fastin
g
Blood Glucose
(or
Hemoglobin A1C
)
Thyroid Stimulating Hormone
Serum
Vitamin B12
Labs
Axonal Neuropathy
Suspected
First-line
Hemoglobin A1C
HIV Test
Lyme
Antibody
test
Rapid Plasma Reagin
(RPR) or
VDRL
Antinuclear Antibody
(ANA)
P-
ANCA
and C-
ANCA
Second-line (if first-line tests negative or suggest additional specific testing)
Serum Protein Electrophoresis
(
SPEP
)
Urine Protein
Electrophoresis (UPEP)
Urine 24 hour collection for
Heavy Metal
s and porphyria
Paraneoplastic syndrome testing
Diagnostics
Indications
Testing indicated if persistent symptoms or unclear etiology
Distinguishes axonal and demyelinating types of Peripheral Neuropathy
Gene
ral
EMG and NCS used in combination
Differentiate axonal from myelin-infiltrative cause
See
Nerve Conduction Velocity
for Interpretation
Nerve and
Muscle
Transmission
Indications
Nondiagnostic workup for persistent Neuropathy
Demyelinating condition suspected
Acute asymmetric, motor or
Autonomic Neuropathy
Needle
Electromyography
(EMG)
Nerve Conduction Studies
(
Nerve Conduction Velocity
, NCS)
Nerve biopsy
Vasculitis
Amyloidosis
Sarcoidosis
Leukodystrophy
Chronic Inflammatory demyelinating Neuropathy
Additional studies (not commonly indicated)
MRI Brain
Lumbar Puncture
Evaluation
Obtain initial labs above
Treat specific evident causes (e.g.
Diabetic Neuropathy
)
If symptoms persist, obtain diagnostic studies above
Type of Neuropathy based on EMG
Axon
al
Consider second-line and third-line lab testing as listed above
Demyelinating
Uniform: Hereditary Neuropathy
Nonuniform
Acute:
Guillain-Barre Syndrome
Subacute or Chronic: Chronic Inflammatory Demyelinating
Polyneuropathy
Precautions
Red Flags
Progressive ascending weakness (risk of
Respiratory Failure
, e.g.
Guillain Barre Syndrome
)
Central Nervous System
Lesion Symptoms
Altered speech or
Swallowing
Ataxia
or
Double Vision
Hemiparesis
or
Hemiplegia
Altered bowel or
Bladder
function (new retention or
Incontinence
)
Cranial Nerve
Deficit
Management
Neurology
Consultation
indications
Nondiagnostic Neuropathy evaluation
Acute or subacute, severe or progressive Neuropathy
Polyneuropathy
or multifocal Neuropathy
Pure motor Neuropathy
Autonomic Neuropathy
Gene
ral Measures
Neuropathic pain tends to be worse at night (when less distracted or trying to initiate sleep)
Consider physical therapy
Weight loss
Eliminate provocative activities (e.g.
Compression Neuropathy
, poor footwear)
Non-specific measures
Warm soaks
Moisturizing rubs
Desensitizing massage
First-line medications:
Tricyclic Antidepressant
s (NNT 3-4)
Desipramine
Amitriptyline
or
Nortriptyline
Start at 10-30 mg at bedtime
Goal dose 75-100 mg nightly
Second-line medications:
SNRI
(NNT 6-7)
Duloxetine
(
Cymbalta
)
Goal dose 60 mg daily
Venlafaxine
Third-line medications (NNT 7-8)
Gabapentin
(
Neurontin
)
Goal dose 1800-3600 daily divided three times daily
Pregabalin
(
Lyrica
)
Goal dose 300-600 mg daily divided twice daily
Additional measures
Consider combining medications listed above
Lidocaine Patch
Other medications (typically started by neurology)
Lamotrigine
Topomax
Carbamazepine
References
Della-Giustina (2024) Crit Dec Emerg Med 38(10): 27-34
Gallagher in Marx (2002) Rosen's Emergency Med, p. 1506
Pryse-Phillips in Noble (2001) Primary Care, p. 1579
Azhary (2010) Am Fam Physician 81(7): 887-92 [PubMed]
Castelli (2020) Am Fam Physician 102(12): 732-9 [PubMed]
Finnerup (2015) Lancet Neurol 14(2): 162–73 [PubMed]
Hughes (2002) BMJ 324(7335): 466-9 [PubMed]
Type your search phrase here